Inflammatory Mediators in Obstructive Sleep Apnoea Syndrome; Mechanisms of

Status Recruiting

Clinical Trial Summary

Obstructive Sleep Apnea Syndrome (OSAS) is associated with elevated plasma levels of IL-6 and TNF-α, which cannot be accounted for by obesity (Vgontzas et al Sleep Med Rev 2005;9:211-24, Ciftci et al Cytokine 2004;28:87-91].

Obstructive apneas-hypopneas are accompanied by strenuous diaphragmatic contractions before the ensuing arousals and re-establishment of airway patency. We have shown that strenuous diaphragmatic contractions induced by resistive loading lead to elevated plasma levels of IL-6, TNF-α, and IL-1β (Vassi-lakopoulos et al AJRCCM 2002;166:1572-8) with concomitant up-regulation of the cytokines within the diaphragmatic myofibers (Vassilakopoulos et al AJRCCM 2004;170:154-61).

OSAS patients exhibit frequent episodes of hypoxemia during the night. Loaded breathing is a form exercise for the respiratory muscles, and both acute and chronic hypoxia lead to an augmented plasma IL-6 response to exercise compared to normoxia (Lundby et al Eur J Appl Physiol 2004;91:88-93).

In OSAS, monocytes have oxidative stress (Dyugovskaya et al AJRCCM 2002;165:934-9) and produce more cytokines (TNF-α) in vitro (Minoguchi et al Chest 204;126:1473-9).

Hypothesis #1: plasma levels of IL-6 and TNF-α are increased during the night in OSAS patients secondary to the intermittent strenuous diaphragmatic contractions and the episodes of hypoxia-reoxygenation associated with the obstructive apneas-hypopneas.

Hypothesis #2: monocytes from sleep apnea patients, exhibit augmented intracellular expression of IL-6 and TNF-α during the night.

Hypothesis #3: Oxidative stress is a stimulus for cytokine upregulation in OSAS.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01188005
Study type	Interventional
Source	University of Athens
Contact	Georgios K Prezerakos, MD
Phone	00306946337935
Email	gprezerak@yahoo.com
Status	Recruiting
Phase	N/A
Start date	August 2010
Completion date	October 2010

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT05164211` - Didgeridoo Treatment to Improve Pharyngeal Compliance in Obstructive Sleep Apnea-hypopnea Syndrome in Children	N/A
Active, not recruiting	`NCT05049928` - m-Rehab OSA : Impact of a Telerehabilitation Program Associated With CPAP on Severity Markers of Obstructive Sleep Apnea Syndrome	N/A
Not yet recruiting	`NCT04538274` - Trained Patient Involvement to Promote the Resumption of CPAP in Patients Who Have Discontinued Its Use	N/A
Completed	`NCT02967367` - Reliability of Consumer Sleep Trackers in Patients Suffering From Obstructive Sleep Apnea Syndrome	N/A
Completed	`NCT02180672` - Steroids for Pediatric Apnea Research in Kids	Phase 3
Recruiting	`NCT01561677` - Consequences of Obstructive Sleep Apnea Syndrome (OSAS) After Ischemic Subtentorial Stroke.	N/A
Completed	`NCT01193738` - Osteopathy and Obstructive Sleep Apnea Syndrome	N/A
Completed	`NCT01808508` - Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome	N/A
Completed	`NCT01090297` - Continuous Positive Airway Pressure (CPAP) Mode Impact on Clinical Blood Arterial Pressure	N/A
Completed	`NCT00850876` - Heated Humidified Continuous Positive Airway Pressure and Nasal Physiology	N/A
Completed	`NCT00801671` - Russian Study of the Effect of Continuous Positive Airway Pressure (CPAP) in Hypertension	Phase 3
Completed	`NCT02085720` - Prevalence of OSAS in Chinese Elderly and Its CPAP Compliance	N/A
Recruiting	`NCT00874913` - Study of Ocular Blood Flow in Patients With Glaucoma and/or Obstructive Sleep Apnea Syndrome (OSAS)	N/A
Completed	`NCT00156442` - A Study to Examine the Relationship Between Sleep Apnea and Cleft Lip/Palate	N/A
Withdrawn	`NCT00156455` - Sleep Disordered Breathing in Children With Single Ventricle Physiology	N/A
Completed	`NCT00222963` - Pilot Study to Assess the Effectiveness of Tonsil and Adenoidectomy (T+A) in Overweight Children and Adolescents	N/A
Completed	`NCT01045499` - LAGB as a Treatment for Morbid Obesity in Adolescents	N/A
Completed	`NCT02995837` - Cerebral Blood Flow and Childhood Obstructive Sleep Apnea
Withdrawn	`NCT02559427` - SPA Therapy in the Treatment of Sleep Apnea Syndrome	N/A
Completed	`NCT02522819` - Feasibility Evaluation of CPAP in the Treatment of Obstructive Sleep Apnea Synchrone in the Acute Phase of Stroke	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Inflammatory Mediators in Obstructive Sleep Apnoea Syndrome; Mechanisms of Production and the Effect of Long Term Antioxidants Administration

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms